Esophageal n (%) | Gastric n (%) | ||||
---|---|---|---|---|---|
Users | Never-users | Users | Never-users | ||
Year of diagnosis | 1998–2002 | 85 (25%) | 482 (20%) | 116 (31%) | 507 (25%) |
2003–2007 | 123 (36%) | 789 (33%) | 126 (34%) | 719 (36%) | |
2008–2013 | 135 (39%) | 1094 (46%) | 130 (35%) | 779 (39%) | |
Age at diagnosis: mean | 74.5 | 68.2 | 76.5 | 69.6 | |
< 60 | 25 (7%) | 564 (24%) | 21 (6%) | 408 (20%) | |
60–69 | 86 (25%) | 755 (32%) | 64 (17%) | 506 (25%) | |
70–79 | 124 (36%) | 655 (28%) | 150 (40%) | 698 (35%) | |
80+ | 108 (31%) | 391 (17%) | 137 (37%) | 393 (20%) | |
Gender | Male | 217 (63%) | 1611 (68%) | 241 (65%) | 1368 (68%) |
Deprivation quintile | 1 (least deprived) | 63 (18%) | 501 (21%) | 68 (18%) | 381 (19%) |
2 | 86 (25%) | 602 (25%) | 93 (25%) | 480 (24%) | |
3 | 70 (20%) | 469 (20%) | 61 (16%) | 413 (21%) | |
4 | 71 (21%) | 446 (19%) | 81 (22%) | 429 (22%) | |
5 (most deprived) | 53 (15%) | 346 (15%) | 69 (19%) | 299 (15%) | |
Treatment | Surgery | 125 (36%) | 959 (41%) | 181 (49%) | 1029 (51%) |
Chemotherapy | 116 (34%) | 1178 (50%) | 76 (20%) | 784 (39%) | |
Radiotherapy | 108 (31%) | 591 (25%) | 30 (8%) | 130 (6%) | |
Tumor type | Adenocarcinoma | 214 (62%) | 1391 (59%) | 303 (81%) | 1581 (79%) |
Squamous | 99 (29%) | 716 (30%) | <5a | 19 (1%) | |
Others | 30 (9%) | 258 (11%) | 64-69a | 405 (20%) | |
Grade | 1 | 17 (7%) | 92 (5%) | 18 (7%) | 69 (5%) |
2 | 131 (53%) | 775 (44%) | 103 (40%) | 484 (33%) | |
3 | 93-98a | 892 (50%) | 132-137a | 892 (61%) | |
4 | <5a | 16 (1%) | <5a | 17 (1%) | |
Missing | 97 | 590 | 114 | 543 | |
Stage | 1 | 8 (17%) | 36 (8%) | 7 (16%) | 33 (12%) |
2 | 10 (21%) | 86 (18%) | 9 (21%) | 54 (20%) | |
3 | 20 (43%) | 208 (44%) | 8 (19%) | 67 (28%) | |
4 | 9 (19%) | 143 (30%) | 19 (44%) | 116 (43%) | |
Missing | 296 | 1892 | 329 | 1735 | |
Other medication useb | Statin | 133 (39%) | 553 (23%) | 164 (44%) | 479 (24%) |
Aspirin | 146 (43%) | 423 (18%) | 132 (35%) | 366 (18%) | |
Smoking | Never | 101 (43%) | 701 (39%) | 103 (39%) | 609 (42%) |
Former | 94 (40%) | 621 (35%) | 123 (46%) | 510 (35%) | |
Current | 42 (18%) | 473 (26%) | 39 (15%) | 318 (22%) | |
Missing | 106 | 570 | 107 | 568 | |
Alcohol consumption | Never | 36 (16%) | 235 (15%) | 51 (20%) | 243 (18%) |
Former | 7 (3%) | 63 (4%) | 12 (5%) | 45 (3%) | |
Current | 184 (81%) | 1322 (82%) | 191 (75%) | 1030 (78%) | |
Missing | 116 | 745 | 118 | 687 | |
BMI | Underweight (< 18.5) | 6 (3%) | 68 (5%) | <5a | 50 (4%) |
Normal (18.5–24.9) | 63 (29%) | 549 (38%) | 64-69a | 429 (35%) | |
Overweight (25–29.9) | 86 (39%) | 531 (37%) | 91 (39%) | 504 (41%) | |
Obese (≥30) | 63 (29%) | 300 (21%) | 74 (32%) | 238 (19%) | |
Missing | 125 | 917 | 138 | 784 | |
Selected comorbidities | Heart failure | 51 (15%) | 58 (2%) | 64 (17%) | 61 (3%) |
Myocardial infarction | 38 (11%) | 124 (5%) | 48 (13%) | 115 (6%) | |
Hypertension | 187 (55%) | 979 (41%) | 217 (58%) | 826 (41%) | |
Edema | 79 (23%) | 185 (8%) | 86 (23%) | 148 (7%) |